BMRA
BIOMERICA INC
NASDAQ · Healthcare · Medical - Devices · US
$2.51
+6.36%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$2.34
From 52W high−21.56%
Volume75411.00
Market cap$11.52M
P/E (TTM)—
P/S (TTM)2.6x
Div yield—
Key dataSep 18, 2026
Open
$2.34
From 52W high
−21.56%
Volume
75411.00
Market cap
$11.52M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−3.2x
P/E (TTM)
—
RSI (14)
65.3
MomentumView details →
1D Return
+6.36%
YTD Return
−8.33%
SummaryUpdated May 1, 2026
Biomerica, Inc. (NASDAQ:BMRA) is a biomedical technology company founded in 1971 and headquartered in Irvine, California. The company went public in 1984 and has spent over five decades developing, manufacturing, and marketing diagnostic and therapeutic products for medical conditions worldwide. Biomerica operates in the medical devices sector, focusing primarily on diagnostic test kits for gastrointestinal diseases, food intolerances, diabetes, and other medical conditions. The company has evolved from a traditional diagnostic test manufacturer to include therapeutic product development, particularly in the irritable bowel syndrome treatment space.
Similar companies
Latest newsMore news →
Biomerica, Inc. entered into a Securities Purchase Agreement with certain institutional and individual investors to issue and sell 1,393,705 shares of common stock at $1.60 per share, raising approximately $2.23 million in gross proceeds, with the closing occurring on August 26, 2026.25d agoBiomerica Inc. signed a $500,000 secured promissory term note due 2027, bearing 8% annual interest and maturing 12 months from its May 29, 2026 issuance date, secured by its shares in Diagnosis S.A.108d ago